Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Non-cash Items: 2018-2025

Historic Non-cash Items for Aytu Biopharma (AYTU) over the last 8 years, with Sep 2025 value amounting to $103,898.

  • Aytu Biopharma's Non-cash Items rose 64.76% to $103,898 in Q3 2025 from the same period last year, while for Sep 2025 it was $103,898, marking a year-over-year increase of 64.76%. This contributed to the annual value of $100,000 for FY2025, which is 50.00% down from last year.
  • Per Aytu Biopharma's latest filing, its Non-cash Items stood at $103,898 for Q3 2025, which was up 3.90% from $100,000 recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Non-cash Items registered a high of $300,000 during Q3 2021, and its lowest value of $2,664 during Q4 2022.
  • Its 3-year average for Non-cash Items is $99,424, with a median of $100,000 in 2025.
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 3,198.52% in 2021, then tumbled by 99.11% in 2022.
  • Aytu Biopharma's Non-cash Items (Quarterly) stood at $300,000 in 2021, then crashed by 99.11% to $2,664 in 2022, then skyrocketed by 668.39% to $20,470 in 2023, then surged by 297.65% to $81,399 in 2024, then spiked by 64.76% to $103,898 in 2025.
  • Its last three reported values are $103,898 in Q3 2025, $100,000 for Q2 2025, and $200,000 during Q1 2025.